Peripheral arterial disease – Your questions answered

   Rated 5 / 5 stars

Save

CPD for this activity

Educational Activities (EA)

0.5 hours

These are activities that expand general practice knowledge, skills and attitudes, related to your scope of practice.

Reviewing Performance (RP)

0.5 hours

These are activities that require reflection on feedback about your work.

Measuring Outcomes (MO)

0 hours

These are activities that use your work data to ensure quality results.

EA
0.5 hours

Educational Activities (EA)
These are activities that expand general practice knowledge, skills and attitudes, related to your scope of practice.

RP
0.5 hours

Reviewing Performance (RP)
These are activities that require reflection on feedback about your work.

MO
0 hours

Measuring Outcomes (MO)
These are activities that use your work data to ensure quality results.

Listen to the episode

Description

The questions answered in this podcast are listed below.
They were compiled by GPs and health professionals around Australia.

  1. Tell us exactly what we’re talking about when we say peripheral artery?
  2. What about the incidence of peripheral arterial disease? Is it improving because less people are smoking or are you seeing no change in the incidents?
  3. How do these diseases present to general practitioners?
  4. How do mesenteric arteries and renal arteries present?
  5. If a patient developed small bowel infarction what is the mortality rate?
  6. What could help GPs lower the threshold and increase index of suspicion?
  7. How bad do your kidneys need to be before you start developing peripheral artery disease?
  8. What about the presence of some very significant proteinuria?
  9. Would you rate carotids as a peripheral arterial disease?
  10. How hard should GPs look for other vascular disease in a patient who either has peripheral arterial disease or coronary arterial disease or cerebral vascular disease?
  11. What are the red flags?
  12. Case: A patient with significant peripheral arterial disease who is being managed by a cardiologist and is stable enough for medical treatment, with no immediate need for surgical intervention. What lies ahead for these patients, apart from managing their cardiovascular risk factors?
  13. What are the chances that they recur?
  14. How many times can you redo small arteries?
  15. When discussing medical treatment, are you referring to the full range of polypharmacy, including medications for hypertension (antihypertensives), cholesterol management (statins), and blood clot prevention (antiplatelet drugs like aspirin)? And if so, are some medications more effective than others in these cases?
  16. Are there any special considerations for GPs when managing patients who are on both a DOAC and an antiplatelet agent, or those on triple therapy?

 

Expert: Dr Shannon Thomas, Vascular and Endovascular Surgeon

Host: Dr David Lim, GP and Medical Educator

Total time: 39 mins

 

Last Updated: 11 Feb, 2025

Rate this podcast
Help your colleagues find podcasts they'll enjoy by rating this podcast out of five stars.

Icon 2

NEXT LIVE Webcast

:
Days
:
Hours
:
Minutes
Seconds
Prof Richard Harvey

Prof Richard Harvey

Recurrent Nasal Polyps Management – When to Refer

Prof Michelle Giles OAM

Prof Michelle Giles OAM

Practical Strategies to Address Falling Vaccination Rates in Mums and Bubs

Dr Emily Nash

Dr Emily Nash

Abnormal Liver Function Test Interpretation

Prof Kelly-Anne Phillips

Prof Kelly-Anne Phillips

Breast Density and Cancer Risk – What Every GP Can Put into Practice Tomorrow

Join us for the next free webcast for GPs and healthcare professionals

High quality lectures delivered by leading independent experts

You have completed the Educational Activities (EA) component of this activity.

Select ‘Confirm & claim CPD‘ to confirm you have engaged with this activity in its entirety and claim your CPD.

You will be taken to explore further CPD learning available to you.

Upcoming Healthed Webcast

Abnormal Liver Function Test Interpretation

Tuesday 31st March, 7pm - 9pm AEDT

Speaker

Dr Emily Nash

Gastroenterologist and Hepatologist; Chris O'Brien Lifehouse; Clinical Associate Lecturer, University of Sydney

Join Dr Emily Nash for their lecture where they will offer a framework to interpret abnormal LFTS and suggest diagnostic algorithms to help determine the most appropriate next step.